Background
Prognosis parameter | Score |
---|---|
General condition | |
Poor (performance status 10–40%) | 0 |
Moderate (performance status 50–70%) | 1 |
Good (performance status 80–100%) | 2 |
Number of bone metastases outside spine | |
>2 | 0 |
≤2 | 1 |
0 | 2 |
Metastasis to major organs | |
Non-removable | 0 |
Removable | 1 |
None | 2 |
Primary site | |
Lung, osteosarcoma, stomach, bladder, esophagus, pancreas | 0 |
Liver, gallbladder, unidentified | 1 |
Other | 2 |
Kidney, uterus | 3 |
Rectum | 4 |
Thyroid, breast, prostate, carcinoid tumor | 5 |
Palsy | |
Complete (Frankel A, B) | 0 |
Incomplete (Frankel C, D) | 1 |
None (Frankel E) | 2 |
Methods
Age (years) | Sex | Primary tumor type | Revised Tokuhashi score | Complication | Survival period (month) | Preoperative Frankel scorea
| Postoperative Frankel scorea
| Initial stageb
| |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
General condition | Extraspinal bone metastases | Vertebral metastases | Internal organ | Primary site | Palsy | Tokuhashi score | |||||||||
LK | |||||||||||||||
1 | 78 | f | Lung | 0 | 2 | 0 | 2 | 0 | 1 | 5 | 9 | C | D | 3 | |
2 | 81 | f | Lung | 0 | 2 | 1 | 2 | 0 | 1 | 6 | 35 | C | D | 4 | |
3 | 87 | f | Lung | 0 | 2 | 2 | 0 | 0 | 1 | 5 | 4 | C | D | 1 | |
4 | 72 | m | Lung | 0 | 2 | 0 | 2 | 0 | 1 | 5 | 3 | C | D | 4 | |
5 | 60 | f | Lung | 1 | 2 | 1 | 2 | 0 | 1 | 7 | 26 | D | D | 4 | |
6 | 86 | f | Lung | 0 | 2 | 0 | 2 | 0 | 1 | 5 | 12 | C | D | 4 | |
7 | 82 | m | Lung | 0 | 1 | 0 | 0 | 0 | 0 | 1 | infection | 1 | A | A | 3 |
8 | 72 | m | Lung | 0 | 1 | 2 | 2 | 0 | 1 | 6 | 3 | C | C | 4 | |
9 | 65 | m | Lung | 1 | 2 | 0 | 0 | 0 | 1 | 4 | 8 | C | D | 4 | |
10 | 69 | f | Lung | 0 | 1 | 0 | 2 | 0 | 1 | 4 | 7 | C | D | 4 | |
Average | 75.2 ± 9.1 | 0.2 ± 0.4 | 1.7 ± 0.5 | 0.6 ± 0.8 | 1.4 ± 1.0 | 0 | 0.9 ± 0.3 | 4.8 ± 1.6 | 10.8 ± 11.1 | ||||||
PB | |||||||||||||||
11 | 76 | m | Prostate | 0 | 2 | 2 | 2 | 5 | 1 | 12 | 62 | C | D | 4 | |
12 | 74 | m | Prostate | 1 | 2 | 1 | 2 | 5 | 1 | 12 | 11 | D | D | 3 | |
13 | 68 | m | Thyroid | 1 | 2 | 2 | 2 | 5 | 1 | 13 | 53 | D | D | 4 | |
14 | 84 | f | Breast | 0 | 2 | 1 | 2 | 5 | 1 | 11 | 44 | C | D | 1 | |
15 | 55 | f | Breast | 1 | 0 | 2 | 2 | 5 | 1 | 11 | 40 | D | D | 4 | |
16 | 70 | m | Prostate | 0 | 1 | 2 | 2 | 5 | 0 | 10 | 24 | B | D | 4 | |
17 | 72 | m | Prostate | 1 | 2 | 0 | 2 | 5 | 1 | 11 | infection | 27 | D | D | 4 |
18 | 66 | f | Thyroid | 1 | 2 | 1 | 2 | 5 | 1 | 12 | 26 | D | D | 4 | |
19 | 88 | m | Prostate | 0 | 2 | 0 | 2 | 5 | 0 | 9 | 10 | A | A | 4 | |
20 | 62 | f | Breast | 2 | 2 | 2 | 2 | 5 | 1 | 14 | 26 | D | D | 4 | |
21 | 58 | m | Prostate | 0 | 2 | 0 | 0 | 5 | 1 | 8 | 3 | C | D | 4 | |
22 | 73 | m | Prostate | 0 | 1 | 0 | 2 | 5 | 1 | 9 | 5 | C | D | 4 | |
Average | 70.5 ± 9.7 | 0.6 ± 0.7 | 1.7 ± 0.7 | 1.1 ± 0.9 | 1.8 ± 0.6 | 5 | 0.8 ± 0.4 | 11.0 ± 1.8 | 27.6 ± 19.0 | ||||||
OT | |||||||||||||||
23 | 71 | f | Rectum | 0 | 2 | 2 | 0 | 4 | 1 | 9 | 19 | D | D | 2 | |
24 | 76 | m | Kidney | 0 | 2 | 2 | 2 | 3 | 1 | 10 | 8 | D | D | 1 | |
25 | 71 | m | Kidney | 0 | 2 | 0 | 0 | 3 | 1 | 6 | 7 | C | D | 4 | |
26 | 83 | m | Rhabdomyosarcoma | 0 | 2 | 2 | 2 | 2 | 1 | 9 | 3 | C | C | 4 | |
27 | 78 | m | Kidney | 0 | 2 | 0 | 2 | 3 | 1 | 8 | infection | 5 | C | C | 4 |
28 | 87 | m | Unknown | 0 | 2 | 2 | 2 | 1 | 1 | 8 | 8 | C | D | 4 | |
29 | 62 | m | Colon | 0 | 2 | 0 | 0 | 2 | 1 | 5 | 2 | C | C | 4 | |
30 | 70 | m | Colon | 0 | 1 | 1 | 0 | 2 | 1 | 5 | 10 | D | D | 3 | |
31 | 79 | f | Multiple myeloma | 0 | 2 | 0 | 2 | 2 | 1 | 7 | 9 | C | C | 4 | |
Average | 75.2 ± 7.6 | 0 | 1.9 ± 0.3 | 1.0 ± 1.0 | 1.1 ± 1.1 | 2.4 ± 0.9 | 1 | 7.4 ± 1.8 | 7.9 ± 5.0 |